- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04495036
Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff
August 3, 2020 updated by: University Hospital, Basel, Switzerland
This study is to investigate the current use and intention to use of teledermatology in Swiss dermatology patients, dermatologists, other physicians and medical staff.
Study Overview
Status
Completed
Conditions
Detailed Description
Telemedicine, the use of telecommunication and information technology to provide clinical health care from a distance, has become an increasing role in basic medical care internationally.
Telemedicine is particularly suitable for skin diseases.
In order to improve the use of evidence-based telemedicine, the Swiss patients' preferences regarding teledermatology versus face-to-face consultations and the patients' and physicians' determinants of acceptance for teledermatology are investigated in this study.
Dermatology patients are asked to complete a newly-created 21-items-survey; Swiss dermatologists, other physicians and medical staff on telemedicine will complete a similar newly-created, 23-items-questionnaire.
A descriptive statistical analysis (e.g.
gender, age, place of residence (city or country), waiting time) will be performed.
Study Type
Observational
Enrollment (Actual)
683
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarau, Switzerland, 5001
- Kantonsspital Aarau
-
Basel, Switzerland, 4031
- Department of Dermatology, University Hospital Basel
-
Zürich, Switzerland, 8091
- University Hospital Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients treated in the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich and Dermatologists, other physicians and medical staff of the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich.
Description
Inclusion Criteria:
- patients treated in the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich
- dermatologists, other physicians and medical staff of the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
dermatology patients
|
Dermatology patients are asked to complete a 21-items-survey while waiting for the doctor's consultation. Following variables will be addressed:
|
|
physicians and medical staff
|
To obtain the view of Swiss dermatologists, other physicians and medical staff on telemedicine a 23-items-survey will be completed. Following variables will be addressed:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
descriptive analysis: deviation in influencing factors for the acceptance of teledermatology
Time Frame: at baseline
|
Assessment of the deviation in influencing factors for the acceptance of teledermatology (subjective disease perception versus objective assessment by physicians)
|
at baseline
|
|
descriptive analysis of the impact of medical education for the acceptance of telemedicine among dermatologists vs. other physicians vs. medical staff vs. patients
Time Frame: at baseline
|
Comparison of the impact of medical education for the acceptance of telemedicine among dermatologists vs. other physicians vs. medical staff vs. patients
|
at baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2019
Primary Completion (ACTUAL)
January 31, 2020
Study Completion (ACTUAL)
January 31, 2020
Study Registration Dates
First Submitted
July 28, 2020
First Submitted That Met QC Criteria
July 28, 2020
First Posted (ACTUAL)
July 31, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 4, 2020
Last Update Submitted That Met QC Criteria
August 3, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Req-2019-00523; sp20Maul2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dermatologic Disease
-
University of California, IrvineBeckman Laser Institute University of California IrvineRecruitingDermatologic DiseasesUnited States
-
DermTechRecruitingDermatologic DiseasesUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
National Institute of Arthritis and Musculoskeletal...CompletedDermatologic Diseases | Systemic Diseases With Cutaneous ManifestationsUnited States
-
University of ZurichCompletedDermatologic Disease of Inpatients in Internal MedicineSwitzerland
-
University of ViennaMedical University of ViennaCompletedDermatologic Disorders | Disorder of Cholesterol Metabolism
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbHCompleted
-
Wake Forest University Health SciencesBelleTorus CorporationRecruitingDermatologic DiseaseUnited States
-
University of ManchesterDowager Countess Eleanor Peel TrustRecruiting
-
Hollister IncorporatedLoyola UniversityCompletedDermatologic ComplicationsUnited States
Clinical Trials on data collection (21-items-patient descriptive survey)
-
IRCCS Policlinico S. DonatoASST Grande Ospedale Metropolitano NiguardaCompletedNutrition Disorders in Old AgeItaly
-
M.D. Anderson Cancer CenterLynne Cohen Foundation for Ovarian Cancer ResearchCompletedBreast Cancer | Ovarian CancerUnited States
-
Istanbul Aydın UniversityCompleted
-
University Hospital, Basel, SwitzerlandRecruiting
-
University Hospital, Basel, SwitzerlandCompleted
-
University Hospital, GrenobleCompletedHypertension, PulmonaryFrance
-
University Hospital, Basel, SwitzerlandRecruitingFunctional Neurological DisorderSwitzerland
-
Novartis PharmaceuticalsActive, not recruitingChronic Spontaneous UrticariaGermany
-
University Hospital, Basel, SwitzerlandWithdrawnAdult Patients With Suspected Meningitis and/or EncephalitisSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedHeart Implant ComplicationSwitzerland